PESI
Information
Rising Resistance, Long-Acting Solutions: A Pharmacology Update for STI and HIV Management
Copyright :
Description
- Resistance is rising: Latest protocols for multidrug-resistant gonorrhea and Mycoplasma genitalium
- Implement injectables: Cabotegravir and twice-yearly lenacapavir to solve pill fatigue and modernize your PrEP practice
- Navigate the bicillin shortage, updated syphilis algorithms, and key guideline changes across chlamydia, gonorrhea, and PID
The clinical landscape for infectious diseases is moving faster than ever, and clinicians are experiencing a pivotal shift in how HIV and STIs are managed. This presentation isn't just a refresher; it’s a high-impact roadmap to mastering long-acting therapies. You will learn how to select and prescribe medications for STIs, confidently provide PrEP, and understand strategies for transitioning patients to new therapeutic options.
Gain the ability to implement the latest twice-yearly injectables, address drug shortages using imported alternatives, and apply new pharmacological approaches to combat "pill fatigue." You’ll be prepared to go beyond standard protocols, using targeted pharmacotherapy strategies.
Speakers
Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC

